94 related articles for article (PubMed ID: 5761059)
1. Anticoagulant therapy standards: results of two national surveys.
Poller L
Thromb Diath Haemorrh Suppl; 1968; 35():115-2. PubMed ID: 5761059
[No Abstract] [Full Text] [Related]
2. Stability studies on lyophilised reference thromboplastins for standardisation of prothrombin-times.
Poller L; Thomson JM; Yee KF
Lancet; 1977 Nov; 2(8046):1019-22. PubMed ID: 72911
[TBL] [Abstract][Full Text] [Related]
3. Considerations on an international standard for the one-stage prothrombin time in the control of anticoagulant therapy.
Loeliger EA; Hemker HC
Thromb Diath Haemorrh Suppl; 1968; 35():101-5. PubMed ID: 4953165
[No Abstract] [Full Text] [Related]
4. The standardization of the prothrombin time for the control of anticoagulant therapy.
Biggs R
Thromb Diath Haemorrh Suppl; 1968; 35():87-92. PubMed ID: 5761075
[No Abstract] [Full Text] [Related]
5. A comparative study of several thromboplastins used to measure the one-stage prothrombin time.
Littell AS; Ratnoff OD
Thromb Diath Haemorrh Suppl; 1968; 35():135-48. PubMed ID: 5761061
[No Abstract] [Full Text] [Related]
6. Fourth report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Denson KW
Thromb Diath Haemorrh Suppl; 1968; 35():197-208. PubMed ID: 5761492
[No Abstract] [Full Text] [Related]
7. Critical appraisal, clinical usefulness, and implementation of the thromboplastin concept of prothrombin-time standardization.
Loeliger EA; van den Besselaar AM; Bertina RM
Scand J Haematol Suppl; 1980; 37():34-48. PubMed ID: 7017900
[No Abstract] [Full Text] [Related]
8. Third report on the standardization of the one-stage prothrombin time for the control of anticoagulant therapy.
Biggs R; Denson KW
Thromb Diath Haemorrh Suppl; 1967; 26():445-50. PubMed ID: 6064876
[No Abstract] [Full Text] [Related]
9. Standardization of the prothrombin time: clinical results with a recombinant tissue factor reagent.
Kolde HJ
Haematologica; 1995; 80(2 Suppl):7-13. PubMed ID: 7628775
[No Abstract] [Full Text] [Related]
10. Discrepant sensitivity of thromboplastin reagents to clotting factor levels explored by the prothrombin time in patients on stable oral anticoagulant treatment: impact on the international normalized ratio system.
Testa S; Morstabilini G; Fattorini A; Galli L; Denti N; D'Angelo A
Haematologica; 2002 Dec; 87(12):1265-73. PubMed ID: 12495900
[TBL] [Abstract][Full Text] [Related]
11. Calibration of five different thromboplastins, using fresh and freeze-dried plasma.
Bangham DR; Biggs R; Brozović M; Denson KW
Thromb Diath Haemorrh; 1973 May; 29(2):228-39. PubMed ID: 4796944
[No Abstract] [Full Text] [Related]
12. International and national standardization of control of anticoagulant therapy in patients receiving coumarin and indanedione drugs using calibrated thromboplastin preparations.
Denson KW
J Clin Pathol; 1971 Jul; 24(5):460-3. PubMed ID: 5571838
[No Abstract] [Full Text] [Related]
13. Effect of melagatran on prothrombin time assays depends on the sensitivity of the thromboplastin and the final dilution of the plasma sample.
Mattsson C; Menschiek-Lundin A; Wåhlander K; Lindahl TL
Thromb Haemost; 2001 Aug; 86(2):611-5. PubMed ID: 11522011
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the quality of prothrombin time technique in the Basque Country].
Vacas M; Lafuente PJ; Aguirrebeitia MJ; Iriarte JA
Sangre (Barc); 1998 Feb; 43(1):41-5. PubMed ID: 9577180
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulant activity of Heraclenin.
Mishra KC; Sharma RC; Sharma YN; Arora RB
Indian J Physiol Pharmacol; 1969 Jul; 13(3):153-5. PubMed ID: 5362630
[No Abstract] [Full Text] [Related]
16. Proposed specification for a reference thromboplastin preparation for the control of anticoagulant therapy using coumarin type drugs.
Denson KW
Thromb Diath Haemorrh Suppl; 1967; 26():437-40. PubMed ID: 6064874
[No Abstract] [Full Text] [Related]
17. Field study of lyophilized calibrant plasmas for fresh plasma INR determination.
van den Besselaar AM; Houbouyan-Réveillard LL
Thromb Haemost; 2002 Feb; 87(2):277-81. PubMed ID: 11859852
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of international normalized ratios by a controlled field survey with 4 different thromboplastin reagents.
Kazama M; Suzuki S; Abe T; Tahara C; Shimazu C; Akiyama Y; Higashi K; Ishiguro I; Kimura T; Motoi S
Thromb Haemost; 1990 Dec; 64(4):535-41. PubMed ID: 2084938
[TBL] [Abstract][Full Text] [Related]
19. Studies on 4-hydroxy-I-thiacoumarins: VI--anticoagulant activity and chemical structure in 4-hydroxy-I-thiacoumarins and related compounds.
Jamkhandi PS; Rajagopal S; Sirsi M
Indian J Exp Biol; 1968 Oct; 6(4):224-6. PubMed ID: 5720680
[No Abstract] [Full Text] [Related]
20. Effect of long-term anticoagulant therapy on antithrombin activity.
Kenedi I; Dózsán G; Péter M
Ther Hung; 1965; 13(2):57-8. PubMed ID: 5844088
[No Abstract] [Full Text] [Related]
[Next] [New Search]
